GreenLight to Present at the BIO World Congress on Industrial Biotechnology

July 18, 2017

BOSTON, July 18, 2017 /PRNewswire/ — GreenLight Biosciences, Inc., a biotechnology company producing novel RNA-based products for agricultural, healthcare and other applications, today announced that management will present at the BIO World Congress on Industrial Biotechnology at the Palais des Congres in Montreal, Canada.  The presentation entitled “A novel platform for development of double-stranded RNA agricultural products” will be delivered by Dr. Andrey J. Zarur, Chairman and CEO of GreenLight, on Wednesday July 26th at 10:30 a.m. ET.

The content of the presentation will be available online from the Media page of the Company’s website at

About GreenLight
GreenLight Biosciences, Inc., is a leader in the development and manufacturing of nucleic acid materials for research, agricultural and healthcare applications. GreenLight’s Cell-free Bioprocessing platform enables unprecedented precision, low cost and scalability in the production of RNA-based materials, enabling a broad range of products for pest control and other important agricultural applications.  GreenLight is a private company backed by a leading syndicate of notable investors.

Media contact: [email protected]